Sökning: "CDK2"
Visar resultat 1 - 5 av 25 avhandlingar innehållade ordet CDK2.
1. FET proteins in cancer and development
Sammanfattning : Chromosomal translocations leading to rearrangements of FET family genes (FUS, EWSR1 and TAF15) are found in numerous human cancers. These genetic alterations result in the formation of fusion oncogenes that express potent chimeric oncoproteins able to promote tumor development. LÄS MER
2. Targeting MYC and CDK2 in cancer : impacts on senescence, apoptosis and immune modulation
Sammanfattning : Cancer is a disease in which cells acquire the ability to divide uncontrollably and invade other tissues. An important component of this process is the activation of oncogenes and inactivation of tumor suppressor genes. LÄS MER
3. Modulating the activity of the c-Myc oncoprotein : implications for therapeutic treatment
Sammanfattning : The Myc oncoprotein regulates numerous cellular processes and is frequently deregulated in cancer due to genetic lesions. However, in addition to its tumor promoting activity, Myc and other oncoproteins induce intrinsic safe-guard mechanisms against tumorigenesis like apoptosis and cellular senescence, which have to be overcome by additional genetic lesions for cellular transformation. LÄS MER
4. Signaling pathways in the development of female germ cells
Sammanfattning : Primordial follicles are the first small follicles to appear in the mammalian ovary. Women are born with a fixed number of primordial follicles in the ovaries. Once formed, the pool of primordial follicles serves as a source of developing follicles and oocytes. LÄS MER
5. Vascular development and safeguard mechanisms against tumorigenesis : oncogene-induced apoptosis and cellular senescence
Sammanfattning : Angiogenesis, apoptosis and senescence are all cellular processes that have an impact on tumor development. Angiogenesis or the new vessel formation from pre-existing ones is known to be required for invasive tumor growth and metastasis. LÄS MER